Phosphatidylserine monolayers as models for drug uptake into membranes and tissue.
Scheufler
E
E
Janssen Research Foundation, Neuss, FRG.
Peters
T
T
D000818:Animals; D001011:Aorta / Q000166:cytology / Q000378:metabolism / Q000648:ultrastructure; D052160:Benzothiazoles; D002462:Cell Membrane / Q000378:metabolism* / Q000648:ultrastructure; D004110:Diltiazem / Q000493:pharmacokinetics; D004910:Erythrocyte Membrane / Q000378:metabolism; D005444:Flunarizine / Q000493:pharmacokinetics; D006325:Heart Atria / Q000166:cytology / Q000378:metabolism / Q000648:ultrastructure; D006801:Humans; D008012:Lidocaine / Q000493:pharmacokinetics; D008567:Membranes, Artificial; D008954:Models, Biological; D009568:Nitrendipine / Q000493:pharmacokinetics; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010599:Pharmacokinetics; D010718:Phosphatidylserines; D010880:Piperidines / Q000493:pharmacokinetics; D051381:Rats; D013844:Thiazoles / Q000493:pharmacokinetics; D014700:Verapamil / Q000493:pharmacokinetics
D052160:Benzothiazoles; D008567:Membranes, Artificial; D004364:Pharmaceutical Preparations; D010718:Phosphatidylserines; D010880:Piperidines; D013844:Thiazoles; C054551:R 56865; D008012:Lidocaine; D009568:Nitrendipine; D014700:Verapamil; D004110:Diltiazem; D005444:Flunarizine